An Observational Study to Learn More About How Safe Treatment With Rivaroxaban is in Children in Japan With Venous Thromboembolism
Clinical trial NCT06278051 · COMPLETED
Trial details
- NCT number
- NCT06278051
- Sponsor
- Bayer
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2024-02-19
- Primary completion
- 2024-11-11
- Enrollment
- 320
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.